285 related articles for article (PubMed ID: 29844361)
1. Dimethyl fumarate induces a persistent change in the composition of the innate and adaptive immune system in multiple sclerosis patients.
Montes Diaz G; Fraussen J; Van Wijmeersch B; Hupperts R; Somers V
Sci Rep; 2018 May; 8(1):8194. PubMed ID: 29844361
[TBL] [Abstract][Full Text] [Related]
2. Dimethyl fumarate influences innate and adaptive immunity in multiple sclerosis.
Diebold M; Sievers C; Bantug G; Sanderson N; Kappos L; Kuhle J; Lindberg RLP; Derfuss T
J Autoimmun; 2018 Jan; 86():39-50. PubMed ID: 28958667
[TBL] [Abstract][Full Text] [Related]
3. Dimethyl fumarate: Regulatory effects on the immune system in the treatment of multiple sclerosis.
Hosseini A; Masjedi A; Baradaran B; Hojjat-Farsangi M; Ghalamfarsa G; Anvari E; Jadidi-Niaragh F
J Cell Physiol; 2019 Jul; 234(7):9943-9955. PubMed ID: 30536402
[TBL] [Abstract][Full Text] [Related]
4. Treatment response to dimethyl fumarate is characterized by disproportionate CD8+ T cell reduction in MS.
Fleischer V; Friedrich M; Rezk A; Bühler U; Witsch E; Uphaus T; Bittner S; Groppa S; Tackenberg B; Bar-Or A; Zipp F; Luessi F
Mult Scler; 2018 Apr; 24(5):632-641. PubMed ID: 28436295
[TBL] [Abstract][Full Text] [Related]
5. Relapsing-Remitting Multiple Sclerosis Is Characterized by a T Follicular Cell Pro-Inflammatory Shift, Reverted by Dimethyl Fumarate Treatment.
Cunill V; Massot M; Clemente A; Calles C; Andreu V; Núñez V; López-Gómez A; Díaz RM; Jiménez MLR; Pons J; Vives-Bauzà C; Ferrer JM
Front Immunol; 2018; 9():1097. PubMed ID: 29896193
[TBL] [Abstract][Full Text] [Related]
6. Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients.
Longbrake EE; Ramsbottom MJ; Cantoni C; Ghezzi L; Cross AH; Piccio L
Mult Scler; 2016 Jul; 22(8):1061-1070. PubMed ID: 26459150
[TBL] [Abstract][Full Text] [Related]
7. Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis.
Traub J; Traffehn S; Ochs J; Häusser-Kinzel S; Stephan S; Scannevin R; Brück W; Metz I; Weber MS
Brain Pathol; 2019 Sep; 29(5):640-657. PubMed ID: 30706542
[TBL] [Abstract][Full Text] [Related]
8. Dimethyl fumarate induces changes in B- and T-lymphocyte function independent of the effects on absolute lymphocyte count.
Longbrake EE; Cantoni C; Chahin S; Cignarella F; Cross AH; Piccio L
Mult Scler; 2018 May; 24(6):728-738. PubMed ID: 28480794
[TBL] [Abstract][Full Text] [Related]
9. Optimal response to dimethyl fumarate associates in MS with a shift from an inflammatory to a tolerogenic blood cell profile.
Medina S; Villarrubia N; Sainz de la Maza S; Lifante J; Costa-Frossard L; Roldán E; Picón C; Álvarez-Cermeño JC; Villar LM
Mult Scler; 2018 Sep; 24(10):1317-1327. PubMed ID: 28653862
[TBL] [Abstract][Full Text] [Related]
10. Increased NK Cell Count in Multiple Sclerosis Patients Treated With Dimethyl Fumarate: A 2-Year Longitudinal Study.
Marastoni D; Buriani A; Pisani AI; Crescenzo F; Zuco C; Fortinguerra S; Sorrenti V; Marenda B; Romualdi C; Magliozzi R; Monaco S; Calabrese M
Front Immunol; 2019; 10():1666. PubMed ID: 31379857
[No Abstract] [Full Text] [Related]
11. Differential effects of disease modifying drugs on peripheral blood B cell subsets: A cross sectional study in multiple sclerosis patients treated with interferon-β, glatiramer acetate, dimethyl fumarate, fingolimod or natalizumab.
Kemmerer CL; Pernpeintner V; Ruschil C; Abdelhak A; Scholl M; Ziemann U; Krumbholz M; Hemmer B; Kowarik MC
PLoS One; 2020; 15(7):e0235449. PubMed ID: 32716916
[TBL] [Abstract][Full Text] [Related]
12. Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.
Wu Q; Wang Q; Mao G; Dowling CA; Lundy SK; Mao-Draayer Y
J Immunol; 2017 Apr; 198(8):3069-3080. PubMed ID: 28258191
[TBL] [Abstract][Full Text] [Related]
13. Dimethyl fumarate treatment in multiple sclerosis: Recent advances in clinical and immunological studies.
Montes Diaz G; Hupperts R; Fraussen J; Somers V
Autoimmun Rev; 2018 Dec; 17(12):1240-1250. PubMed ID: 30316988
[TBL] [Abstract][Full Text] [Related]
14. Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2.
Schulze-Topphoff U; Varrin-Doyer M; Pekarek K; Spencer CM; Shetty A; Sagan SA; Cree BA; Sobel RA; Wipke BT; Steinman L; Scannevin RH; Zamvil SS
Proc Natl Acad Sci U S A; 2016 Apr; 113(17):4777-82. PubMed ID: 27078105
[TBL] [Abstract][Full Text] [Related]
15. Dimethyl fumarate promotes B cell-mediated anti-inflammatory cytokine profile in B and T cells, and inhibits immune cell migration in patients with MS.
Najjar E; Staun-Ram E; Volkowich A; Miller A
J Neuroimmunol; 2020 Jun; 343():577230. PubMed ID: 32247228
[TBL] [Abstract][Full Text] [Related]
16. Dimethyl Fumarate Treatment Mediates an Anti-Inflammatory Shift in B Cell Subsets of Patients with Multiple Sclerosis.
Li R; Rezk A; Ghadiri M; Luessi F; Zipp F; Li H; Giacomini PS; Antel J; Bar-Or A
J Immunol; 2017 Jan; 198(2):691-698. PubMed ID: 27974457
[TBL] [Abstract][Full Text] [Related]
17. High-dimensional immune profiling identifies a biomarker to monitor dimethyl fumarate response in multiple sclerosis.
Diebold M; Galli E; Kopf A; Sanderson NSR; Callegari I; Benkert P; Gonzalo Núñez N; Ingelfinger F; Herms S; Cichon S; Kappos L; Kuhle J; Becher B; Claassen M; Derfuss T
Proc Natl Acad Sci U S A; 2022 Aug; 119(31):e2205042119. PubMed ID: 35881799
[TBL] [Abstract][Full Text] [Related]
18. Effect of dimethyl fumarate on lymphocytes in RRMS: Implications for clinical practice.
Mehta D; Miller C; Arnold DL; Bame E; Bar-Or A; Gold R; Hanna J; Kappos L; Liu S; Matta A; Phillips JT; Robertson D; von Hehn CA; Campbell J; Spach K; Yang L; Fox RJ
Neurology; 2019 Apr; 92(15):e1724-e1738. PubMed ID: 30918100
[TBL] [Abstract][Full Text] [Related]
19. B-cell composition in the blood and cerebrospinal fluid of multiple sclerosis patients treated with dimethyl fumarate.
Høglund RA; Polak J; Vartdal F; Holmøy T; Lossius A
Mult Scler Relat Disord; 2018 Nov; 26():90-95. PubMed ID: 30243235
[TBL] [Abstract][Full Text] [Related]
20. Dimethyl Fumarate Therapy Significantly Improves the Responsiveness of T Cells in Multiple Sclerosis Patients for Immunoregulation by Regulatory T Cells.
Schlöder J; Berges C; Luessi F; Jonuleit H
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
